Study Description

The diagnosed incidence of small bowel neuroendocrine tumors (NETs) is increasing. While patients with localized disease can be treated... Show More

Study Accession Alternative Stable ID type
phs000579.v1.p1 dbGaP Case Set; Tumor vs. Matched-Normal

Who controls access to this study

NCI
Access information:

Publications

Data provider(s)

  • Title Name Institute
    Principal Investigator Matthew Meyerson, MD, PhD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, MA, USA
    Principal Investigator Matthew Kulke, MD Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, MA, USA

Who archives the data?

The database of Genotypes and Phenotypes (dbGaP)